fradafiban has been researched along with Bleeding in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akkerhuis, KM; Baardman, T; Deckers, JW; Hoffmann, J; Peels, HO; Simoons, ML; Stibbe, J; Suryapranata, H; van Den Brand, MJ; van Der Wieken, LR; van Der Zwaan, C | 1 |
1 trial(s) available for fradafiban and Bleeding
Article | Year |
---|---|
Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Area Under Curve; Biphenyl Compounds; Coronary Disease; Double-Blind Method; Female; Hemorrhage; Hemostasis; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prodrugs; Pyrrolidines; Risk | 2001 |